【结 构 式】 |
【药物名称】 【化学名称】[4R-(4α,5α,6β,7β)]-1-(3-Aminobenzyl)-4,7-dibenzyl-5,6- dihydroxy-3-[3-[3(5)-pyrazolyl]benzyl]perhydro-1,3- diazepin-2-one 【CA登记号】 【 分 子 式 】C36H37N5O3 【 分 子 量 】587.72799 |
【开发单位】DuPont Pharm 【药理作用】ANTIINFECTIVE THERAPY,AIDS MEDICINES |
合成路线1
Diol (I) was protected as the bis(methoxymethyl) ether (III) by reaction with methoxymethyl bromide (II) in the presence of diisopropyl ethylamine in DMF, and then, the carbobenzoxy groups of (III) were removed by hydrogenolysis in the presence of Pd/C to afford diamine (IV). Subsequent treatment of (IV) with carbonyl diimidazole (CDI) and pyridine provided the cyclic urea (V). Monoalkylation of (V) with m-iodobenzyl bromide (VI) in the presence KOH and polyethylene glycol in toluene provided the (iodobenzyl)diazepinone (VII). Suzuki coupling of (VII) with the protected pyrazolylboronic acid (VIII) in the presence of Pd(PPh3)4 and K2CO3 afforded the (pyrazolylbenzyl) derivative (IX). Further alkylation of (IX) with m-nitrobenzyl bromide (X) and NaH gave (XI). After deprotection of the methoxymethyl and the (trimethylsilyl)ethoxymethyl groups of (XI) upon treatment with HCl in dioxan-methanol, the title compound was obtained by hydrogenation of the nitro group in the presence of Pd/C.
【1】 Han, Q.; Lam, P.Y.S.; Li, R.; Jadhav, P.K.; Chang, C.-H.; Ru, Y.; Cyclic HIV protease inhibitors: Design and synthesis of orally bioavailable, pyrazole P2/P2' cyclic ureas with improved potency. J Med Chem 1998, 41, 12, 2019. |
【2】 Lam, P.Y.; Eyermann, C.J.; Hodge, C.N.; Jadhav, P.K.; DeLucca, G.V. (DuPont Pharmaceuticals Co.); Cyclic ureas and analogues useful as retroviral protease inhibitors. EP 0607334; EP 0686151; EP 0765873; JP 1995500324; JP 1996509700; US 5610294; WO 9307128; WO 9419329 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19618 | benzyl (1R,2S,3S,4R)-1-benzyl-4-[[(benzyloxy)carbonyl]amino]-2,3-dihydroxy-5-phenylpentylcarbamate | C34H36N2O6 | 详情 | 详情 | |
(II) | 19619 | bromo(methoxy)methane; bromomethyl methyl ether | 13057-17-5 | C2H5BrO | 详情 | 详情 |
(III) | 19620 | benzyl (1R,2S,3S,4R)-1-benzyl-4-[[(benzyloxy)carbonyl]amino]-2,3-bis(methoxymethoxy)-5-phenylpentylcarbamate | C38H44N2O8 | 详情 | 详情 | |
(IV) | 19621 | (2R,3S,4S,5R)-3,4-bis(methoxymethoxy)-1,6-diphenyl-2,5-hexanediamine; (1R,2S,3S,4R)-4-amino-1-benzyl-2,3-bis(methoxymethoxy)-5-phenylpentylamine | C22H32N2O4 | 详情 | 详情 | |
(V) | 19622 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1,3-diazepan-2-one | C23H30N2O5 | 详情 | 详情 | |
(VI) | 19623 | 1-(bromomethyl)-3-iodobenzene | 49617-83-6 | C7H6BrI | 详情 | 详情 |
(VII) | 19633 | (4R,5S,6S,7R)-4,7-dibenzyl-1-(3-iodobenzyl)-5,6-bis(methoxymethoxy)-1,3-diazepan-2-one | C30H35IN2O5 | 详情 | 详情 | |
(VIII) | 19625 | 1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-ylboronic acid | C9H19BN2O3Si | 详情 | 详情 | |
(IX) | 19635 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1-[3-(1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-yl)benzyl]-1,3-diazepan-2-one | C39H52N4O6Si | 详情 | 详情 | |
(X) | 19636 | 1-(bromomethyl)-3-nitrobenzene | 3958-57-4 | C7H6BrNO2 | 详情 | 详情 |
(XI) | 19637 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1-(3-nitrobenzyl)-3-[3-(1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-yl)benzyl]-1,3-diazepan-2-one | C46H57N5O8Si | 详情 | 详情 |